Livongo Health, Inc. Common Stock
LVGO
LVGO was delisted on the 29th of October, 2020.
88 hedge funds and large institutions have $304M invested in Livongo Health, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 88 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
61% more call options, than puts
Call options by funds: $3.57M | Put options by funds: $2.22M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dragoneer Investment Group
San Francisco,
California
|
+$146M |
| 2 |
BlackRock
New York
|
+$37.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.1M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$31.9M |
| 5 |
DCP
D1 Capital Partners
New York
|
+$23.7M |
Top Sellers
LVGO Hedge Fund Activity: Q3 2019 in Review
88 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Livongo Health, Inc. Common Stock (LVGO) for Q3 2019, worth a combined $304M.
Buyers outnumbered sellers: 88 funds opened new LVGO positions and 0 closed out — a net gain of 88 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Dragoneer Investment Group, opening a new position worth an estimated $146M.
- 88 institutional investors held Livongo Health, Inc. Common Stock (LVGO) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $304M of Livongo Health, Inc. Common Stock stock for Q3 2019.
- 88 funds opened new Livongo Health, Inc. Common Stock positions in Q3 2019 and 0 closed out, a net change of +88 holders.
- The largest Livongo Health, Inc. Common Stock buyer in Q3 2019 was Dragoneer Investment Group, an estimated $146M added.
Based on aggregated 13F filings for Q3 2019.